Phase II study of irinotecan and cisplatin as first-line chemotherapy in advanced or recurrent cervical cancer.
Sugiyama T, Yakushiji M, Noda K, Ikeda M, Kudoh R, Yajima A, Tomoda Y, Terashima Y, Takeuchi S, Hiura M, Saji F, Takahashi T, Umesaki N, Sato S, Hatae M, Ohashi Y.
Sugiyama T, et al. Among authors: saji f.
Oncology. 2000;58(1):31-7. doi: 10.1159/000012076.
Oncology. 2000.
PMID: 10644938
Clinical Trial.